Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of the novel HLA-DPA1 allele, DPA1*02:53 by next-generation sequencing. | HLA | 2022 | 34704395 | PubTator, text mining | PubMed |
| A novel allele, HLA-DPA1*01:87Q identified by next generation sequencing. | HLA | 2022 | 34636171 | PubTator, text mining | PubMed |
| Detection of a novel allele, HLA-DPA1*01:58, originating from a recombination within exon 2 of the DPA1 gene. | HLA | 2022 | 34605210 | PubTator, text mining | PubMed |
| Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures. | Cancer Immunol Immunother | 2022 | 34580764 | PubTator, text mining | PubMed |
| Characterization of the novel HLA-DPA1 allele, HLA-DPA1*01:86. | HLA | 2022 | 34536062 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension. | Cardiovasc Res | 2022 | 34528097 | PubTator, text mining | PubMed |
| FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma. | Clin Exp Med | 2022 | 34510311 | PubTator, text mining | PubMed |
| HLA repertoire of 115 UAE nationals infected with SARS-CoV-2. | Hum Immunol | 2022 | 34462158 | PubTator, text mining | PubMed |
| Phase 1 study of oral azacitidine (CC-486) plus R-CHOP in previously untreated intermediate- to high-risk DLBCL. | Blood | 2022 | 34428285 | PubTator, text mining | PubMed |
| T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations. | Nucleic Acids Res | 2022 | 34396391 | PubTator, text mining | PubMed |
| Current and future applications of biomarkers in samples collected through minimally invasive methods for cancer medicine and population-based research. | Am J Hum Biol | 2022 | 34374148 | PubTator, text mining | PubMed |
| Pre-clinical study of human umbilical cord mesenchymal stem cell transplantation for the treatment of traumatic brain injury: safety evaluation from immunogenic and oncogenic perspectives. | Neural Regen Res | 2022 | 34269210 | PubTator, text mining | PubMed |
| Down-regulation of HLA-DRs and HLA-DPs reflects the deficiency of antigen-presenting cells in endometrium from infertile women with and without ovarian endometriosis. | Hum Fertil (Camb) | 2022 | 33787425 | PubTator, text mining | PubMed |
| HLA-A Locus is Associated With Sepsis and Septic Shock After Traumatic Injury. | Ann Surg | 2022 | 33064392 | PubTator, text mining | PubMed |
| Extensive downregulation of immune gene expression by microRNA-140-3p 5' isomiR in an in vitro model of osteoarthritis. | Osteoarthr Cartil Open | 2021 | 36474808 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response. | Front Mol Biosci | 2021 | 35265666 | PubTator, text mining | PubMed |
| Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas. | Front Cell Dev Biol | 2021 | 35223862 | PubTator, text mining | PubMed |
| Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer. | Front Med (Lausanne) | 2021 | 35178409 | PubTator, text mining | PubMed |
| Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways. | J Transl Int Med | 2021 | 35136724 | PubTator, text mining | PubMed |
| Different Types of ANCA Determine Different Clinical Phenotypes and Outcome in ANCA-Associated Vasculitis (AAV). | Front Med (Lausanne) | 2021 | 35127750 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=52